Kuchyne na miru

Top Feature

Sep 10, 2019
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Pharm Exec’s annual feature profiling a selection of notable biopharma brands focuses this year on new beginnings and new promise—spotlighting five products with compelling product launch stories.
Sep 09, 2019
Pharmaceutical Executive
Pharm Exec’s latest analysis of financial performance reveals that it’s those drugmakers maximizing the difference between the value and the cost of their capital investments that are delivering the most bang for the buck to shareholders.
Sep 08, 2019
Pharmaceutical Executive
By Meghan Oates-Zalesky
Expedited reviews drive new imperative for iteration and quality data that enable agility and results. Meghan Oates-Zalesky reports.
Sep 03, 2019
Jill Wechsler casts her eye over the multitude of health reform measures emerging on Capitol Hill.
Aug 22, 2019
Leela Barham talks to Sir David Haslam, the outgoing Chair of UK’s National Institute for Health and Care Excellence (NICE), about the highs and lows of his six-year tenure at the organization.
Aug 13, 2019
Every healthcare company should be striving to identify better ways to ensure patients and consumers inspire every decision they make, writes Joanne Waldstreicher, Johnson & Johnson's Chief Medical Officer.
Aug 12, 2019
Pharmaceutical Executive
Pharm Exec speaks with Geoff MacKay, CEO of AVROBIO, about the company’s mission to advance potentially curative lentiviral-based gene therapies and moving gene therapy into the mainstream.
Aug 10, 2019
Pharmaceutical Executive
Novartis' May announcement of the list price of its new gene therapy for spinal muscular atrophy, Zolgensma, sparked a plethora of heated reactions. But was this a storm in a teacup or a tropical cyclone?
Aug 08, 2019
Pharmaceutical Executive
How to navigate the production and reimbursement intricacies of bringing regenerative medicines from bench to bedside.
Aug 08, 2019
Pharmaceutical Executive
The cell and gene therapy space remains fertile territory for growth, exploration, and discovery. How applying a data-driven model may be the best way to approach this complex ecosystem and assess the innovations of tomorrow.

Facebook targeted ads www.progressive.ua
lorem ipsum